Pharmafile Logo

Cuttsy+Cuttsy becomes employee owned

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

Cuttsy+Cuttsy employees

Cuttsy+Cuttsy founders Caroline Benson and Mathew Cutts are genuinely proud to announce that Cuttsy+Cuttsy (C+C) is now employee owned.

After 15 years of building C+C around a simple belief that people matter – our clients, the patients we ultimately serve, and most of all our team – this marks a hugely meaningful next step in the agency’s story.

“We started Cuttsy+Cuttsy with the belief that you can have a life while working for an agency,” said Caroline and Mathew. “We have always wanted to prove that you can build an ambitious, high-performing agency without losing what matters most. The Employee Ownership Trust (EOT) feels like the natural next move in our journey.”

That people-first approach has been recognised across the industry, including multiple IPA Platinum Awards, being voted one of the top agencies to work for by Campaign magazine, as well as achieving Platinum Investors in People accreditation.

Caroline and Mathew will remain closely involved with the business and continue to hold a minority shareholding, but ownership of C+C is now held in trust on behalf of the team who work within the agency.

“This is about protecting the culture we have built together and making sure C+C continues to thrive for the long term,” they added. “We cannot wait to see where the agency goes next, especially with the team even more invested in shaping its future.”

The move to employee ownership brings stability to the business and reassurance of future ownership for the people who help make Cuttsy+Cuttsy what it is every day.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

Where it all began – why we developed The Experience Gap

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.